(Bloomberg) — Bayer AG’s plan for moving on from its Roundup legal woes hit a snag barely two weeks after it announced a nearly $11 billion settlement of claims the popular weedkiller causes cancer when a judge expressed skepticism about its proposed treatment of future claims.U.S. District Judge Vince Chhabria called the plan to create a class action for future litigants problematic in a court filing Monday and said he was “tentatively inclined” to reject it. He set a July 24 hearing date. Shares of Bayer, which inherited the weedkiller through its purchase of Monsanto, fell as much as 7.1% …read more
Source:: Yahoo Finance
